KCT0005916Recruiting未知
The efficacy and safety of low dose apixaban in patients with non-valvular atrial fibrellation in real world practive: a prospective, multicenter , non-interventional study
Keimyung University Dongsan Hospital0 sites1,673 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,673
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational Study
Eligibility Criteria
- Ages
- 19(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •1)Adult patients over 19 years of age.
- •2)Patients diagnosed with non-valvular atrial fibrillation atrial
- •3)Patients who are taking low-capacity Apixaban with anticoagulant therapy within the last six months of the date of consent in accordance with the drug manual , Patients who did not have a history of the primary and secondary evaluation variables, Clinical Event, or who are scheduled to take Apixaban after taking it
- •4) Patients with a CHA 2 DS2 VASc score of 2 or higher or male patients with a CHA 2 DS2 VASc score of 1
- •5) Patients who meet at least two of the three criteria below
- •A. Cr = 1.5mg /
- •B. age =80 years
- •C. weight =60 kg
Exclusion Criteria
- •1) Those vulnerable to clinical research (Follow KGCP definition)
Investigators
Similar Trials
Recruiting
Unknown
The effect of low-dose apixaban in the treatment of symptomatic cases of radial artery occlusion following radial artery angiography.Radial artery occlusion following angiography.IRCT20221013056161N1Esfahan University of Medical Sciences30
Recruiting
Phase 2
Apixaban in heparin-induced thrombocytopeniaIRCT20200325046854N1Iran University of Medical Sciences30
Recruiting
Phase 3
Comparison of the preventive effects of Apixaban and Enoxaparin on the postoperative vascular thromboembolismIRCT20230419057967N1Bagheiat-allah University of Medical Sciences160
Recruiting
Phase 4
Evaluating the clinical efficacy of Apixaban vs. Warfarin in patients with cerebral venous thrombosis (CVT)Cerebral venous thrombosis.Cerebral infarction due to cerebral venous thrombosis, nonpyogenicI63.6IRCT20240217061039N1Ahvaz University of Medical Sciences74
Recruiting
Phase 3
Apixaban tablet versus Enoxaparin for prevention of venous thromboembolism in women undergoing surgery for gynecological cancersCTRI/2019/07/020134Christian Medical College Vellore